期刊文献+

维生素K2对维甲酸致大鼠骨质疏松症的抑制作用 被引量:1

The inhibitory effect of vitamin K2 on osteoporosis induced by tretinoin in growing female rats
下载PDF
导出
摘要 目的 比较VitK2(20)、K2(35)和柠檬酸-苹果酸钙(CCM)对维甲酸致大鼠骨质疏松症的抑制作用.方法 取60只3月龄雌性大鼠随机均分为正常对照组、模型组、1 mg/kg Vit K2(20)组、0.01 mg/kg Vit K2(35)组、100 mg/kg CCM组和0.125 mg/kg的尼尔雌醇(nilestriol)片阳性对照组.正常对照组以二次蒸馏水10 ml*kg-1*d-1灌胃,其余组按维甲酸70 mg*kg-1*d-1灌胃共15 d,从第9天起上午灌服维甲酸,下午分别灌服VitK2(20)、K2(35)、CCM和尼尔雌醇,灌胃量均为10 ml*kg-1*d-1,连续14 d.结果 与模型组比较,1 mg/kg VitK2(20), 0.01 mg/kg K2(35)和100 mg/kg CCM灌胃给药14 d可明显提高大鼠血清钙含量,显著升高股骨骨密度,并且骨密度与股骨灰重呈线性相关,其中VitK2(35)组的子宫指数、卵巢指数均明显高于其他药物组(P〈0.05);VitK2组骨小梁厚度增加,表面积百分率明显增大,VitK2(35)组的骺板软骨细胞增生明显且有许多新的骨小梁形成.结论 VitK2(20)、K2(35)和CCM对维甲酸致大鼠的骨质疏松症有明显抑制作用,在同等剂量下,VitK2活性约为CCM的102~104倍,VitK2(35)尤为显著. Abstract: Objective To investigate the inhibitory effects of vitamin K2 (20), K2 (35) and calcium citrate malate (CCM) on osteoporosis induced by tretinoin in growing female rats. Methods Sixty three month old female rats were randomly divided into normal group, model group, Vitamin K2 (20) group, Vitamin I(2 ( 35 ) group, CCM group and nilestriol group. The normal group received 10 ml·kg^-1· d^-1 of second distilled water, the other five groups received 70 mg·kg^-1· d^-1 of tretinoin for 15 days, from the ninth day, respectively received additional drugs of 1 mg/kg K2 (20), 0.01 mg/kg K2 (35), 100 mg/kg CCM and 0. 125 mg/kg nilestriol in the afternoon for 14 days. Results The femur bone mineral density(BMD) and the serum level of Ca^2+ was significantly increased in Vit K2 groups and CCM group compared with the model group, while the femur BMD had a positive linear correlation with its bone ash weight, the index of ovarian and uterine of Vit K2 (35) group were significantly higher than other drug groups. Trabecular thickness and percentage of trabecular area in Vit K2 groups were significantly increased more than that of the osteoporotic model, particularly, epiphyseal cartilage cells hyperplasia was very obvious and many new bone trabecular was formed in VitK2 (35)group. Conclusion Vitamin K2 (20), K2 (35) and CCM all have the inhibitory effect on osteoporosis induced by tretinoin, Vit K2 especially K2 (35) is about 102- 104 times more potent than the traditional agents CCM at the same dose.
出处 《中国骨质疏松杂志》 CAS CSCD 2009年第9期664-667,共4页 Chinese Journal of Osteoporosis
基金 国家科技部中小企业创新基金(05C26215301427)
关键词 维生素K2 柠檬酸-苹果酸钙 维甲酸 骨质疏松症 Vitamin K2 Calcium Citrate Malate Tretinoin Osteoporosis
  • 相关文献

参考文献7

二级参考文献27

  • 1李青南,中国药理学报,1994年,15卷,528页
  • 2朱学骏,实用皮肤性病治疗学,1992年
  • 3邵金莺,中药药理与临床,1989年,5卷,25页
  • 4王士凡,药物不良反应,1988年
  • 5细井孝之.骨粗鬆症の予防と治療にぉけるピタミンK2の)新しい意羲.1996,4:201-2081.
  • 6Ichihashi T, Takagishi Y, allchida, et al, Detection and measurement of vitamins kl and k2 in human cortical and trabecular bone. J Bone Miner Res, 1993,8:1005-1008.
  • 7腰原康子.骨形成,in vitro石( )化にぉけるピタミンK2の)作用機序.Osteoporosis Japan 1996,4(2):191-200.
  • 8原久仁子.ビタミンK2(メナテトレノン)の骨代谢改善作用とその特異性.Osteoporosis Japan,1996,4(2):173-182.
  • 9Ducy P, et al. Nature,1996,3824:48-52.
  • 10Koshihara Y, Hoshi K, et al. Vitamin K2 ( menatetrenone ) inhibits prostaglandin synthesis in cultured human osteo-like periosteal cells by inhibiting prostaglandin H synthase activity. Biochem Pharmacol,1993,19,46:1355-1362.

共引文献109

同被引文献12

  • 1朱洪友,雷泽,付正启,等.全反式长链萜烯伯醇的合成方法[P].ZL200710066045.9.
  • 2杨超文.若干醌类药物的合成[D].昆明:云南大学,2005.
  • 3BURCKHARDT P,DAWSON - HUGHES B,HEANEY R P. Nutritional aspects of osteoporosis(骨质疏松营养学)[M].裴福兴,刘洋主,译.北京:人民卫生出版社,2009.
  • 4KOITAYA N, EZAKI J, NISHIMUTA M, et al. Effect of low dose vitamin K2 ( MK - 4) supplementation on bioindices in postmenopausal Japanese women [ J ]. J Nutr Sci Vitamino1,2009,55 : 15-21.
  • 5FESKANICH D, WEBER P, WILLETT W C, et al. Vita- min K intake and hip fracture in women: a prospective study[ J]. Am J Clin Nutr, 1991,69:74-79.
  • 6WILLIAM D. Protecting bone and arterial health with vitamin K2 [J/OL]. LifeExtension (http:/www. lef. org/) ,2008,3 : 1-8.
  • 7LOWE N M,FRASER W D,JACKSON M J. Is there a potential therapeutic value of copper and zinc for osteo- porosis? [J]. Proe Nutr Soe,2002,61(2) :181-185.
  • 8Cees Vermeer, SHEARER M J, Amain Zittermann, et al. Beyond deficiency : Potential benefits of increased in- takes of vitamin K for bone and vascular health[ J]. Eur J Nutr, 2004,43 ( 6 ) :325 -335.
  • 9LEON J, SCHURGERS M J, SHEARER K H, et al. Effect of vitamin K intake on the stability of oral antico- agulant treatment: dose - response relationships in hcahhy subjects[ J]. Blood ,2004,104:2682-2689.
  • 10木晓云,董跃伟,温晓江,付正启,雷泽,方瑞斌,朱洪友.反相高效液相色谱法测定维生素K2(20)[J].云南大学学报(自然科学版),2008,30(4):405-407. 被引量:9

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部